Patient Capital Management’s Crocs CROX Stock Holding History
Bought
Maintained
Sold
Other funds holding CROX
Patient Capital Management's CROX Position: Q2 2026 in Review
Patient Capital Management reduced its Crocs (CROX) stake by 5.2% in Q2 2026, selling an estimated $4.74M and leaving 799,426 shares worth $96.4M. The position accounts for 3.16% of the portfolio, ranked #14.
Patient Capital Management first reported a position in CROX in Q4 2023 and has held it in 11 quarters since. 501 funds tracked by Wall St. Rank hold CROX as of Q2 2026.
- Patient Capital Management held 799,426 shares of Crocs worth $96.4M as of Q2 2026.
- Patient Capital Management sold 43,416 Crocs shares in Q2 2026, an estimated $4.74M.
- Crocs made up 3.16% of Patient Capital Management's portfolio in Q2 2026, its #14 holding.
- Patient Capital Management first reported a position in Crocs in Q4 2023 and has held it in 11 quarters since.
- 501 funds tracked by Wall St. Rank held Crocs as of Q2 2026.
Based on Patient Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.